Virtual Meeting to be held on March 27-28 hosted by BTIG.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OTLK:
- Outlook Therapeutics Issues Convertible Note to Avondale
- Outlook Therapeutics files to sell 7.07M shares of common stock for holders
- Outlook Therapeutics re-submits BLA to U.S. FDA for ONS-5010
- Outlook Therapeutics price target lowered to $10 from $12 at Guggenheim
- Positive Outlook on Outlook Therapeutics: Buy Rating Supported by Strategic Launches and Market Opportunities for Lytenava
Questions or Comments about the article? Write to editor@tipranks.com